March 27, 2026

ACSM Revises Resistance Training Guidance

Synthesized evidence clarifies which training variables enhance strength, hypertrophy, and performance.

Conexiant

March 24, 2026

Reducing the Impact of Climate-Induced Events on Patients and Oncology Staff

Although 2023 made headlines as the hottest year in human history,1 drawing the world closer to breaching the goals outlined in the Paris Agreement to substantially reduce global greenhouse gas emissi...

The ASCO Post

March 18, 2026

AAP, NASPGHAN Issue Guidance on Faltering Weight in Children

New recommendations standardize diagnosis and aim to reduce unnecessary interventions in early childhood growth concerns.

Conexiant

March 16, 2026

Retinal AI Predicts Neonatal Lung Disease

AI models trained on routine ROP images identify bronchopulmonary dysplasia and pulmonary hypertension in premature infants

The Ophthalmologist

February 27, 2026

Latest Clinical Evidence in Extensive-Stage Small Cell Lung Cancer Treatment

Discover the latest strategies in the treatment and management of extensive-stage small cell lung cancer, emphasizing the critical role of supportive care and advancements in therapy. - JADPRO Live.

JADPRO

February 26, 2026

Bringing Advanced Photon Therapy Closer to Home at Atlantic Health Chilton Medical Center

Cancer care today is more advanced, more personalized, and more effective than ever before, and Radiation Oncology plays a central role in that progress.

Atlantic Health System

February 18, 2026

Chemoradiation Plus Atezolizumab in Limited-Stage Small Cell Lung Cancer

As reported in the Journal of Clinical Oncology by Higgins et al, the phase III NRG Oncology/Alliance LU005 trial showed no overall survival benefit with the addition of atezolizumab to concurrent che...

The ASCO Post

February 18, 2026

GSK’s RSV Vaccine Moves Closer to China Approval 

Regulatory filing for Arexvy has been accepted for review in China for adults aged 60 and older, where RSV affects millions each year

The Medicine Maker

February 17, 2026

VA DOD Updates Asthma Framework

The 2025 US Department of Veterans Affairs and US Department of Defense asthma guideline introduces 21 evidence-based recommendations for primary care, redefining stepwise treatment, comorbidity management, and reliever strategy.

Conexiant

February 17, 2026

FDA Approves Once-Monthly Dosing Schedule for Amivantamab and Hyaluronidase-lpuj

When administered in combination with oral lazertinib for the first-line treatment EGFR-mutated advanced NSCLC, monthly dosing delivers consistent outcomes when compared to the previously approved biw...

The ASCO Post